Přihlásit se Zaregistrujte se zdarma

SMA 200 společnosti Panbela Therapeutics

Jaká je hodnota metriky SMA 200 společnosti Panbela Therapeutics?

Hodnota metriky SMA 200 společnosti Panbela Therapeutics Inc. je $1 -51.78%

Jaká je definice metriky SMA 200?



SMA 200 je průměrná cena akcií z posledních 200 dnů vypočítaná jako nevážený průměr předchozích 200 závěrečných cen.

Simple moving average of 200 days for a stock is an unweighted moving average over the past 200 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.

Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.

SMA 200 společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Panbela Therapeutics

Čemu se věnuje společnost Panbela Therapeutics?

Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.

Firmy s metrikou sma 200 podobnou společnosti Panbela Therapeutics